AXNX
Axonics, Inc. · NASDAQ
- Sector Health Technology
- Industry Medical Specialties
- Website axonics.com
- Employees(FY) 610
- ISIN US05465P1012
Performance
+0.22%
1W
+0.31%
1M
-0.31%
3M
+18.47%
6M
+8.55%
YTD
+29.08%
1Y
Profile
Axonics, Inc., a medical technology company, engages in the development and commercialization of novel products for the treatment of bladder and bowel dysfunction. Its sacral neuromodulation (SNM) systems are used to treat patients with overactive bladder (OAB), including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence (FI) and non-obstructive urinary retention (UR); and rechargeable (R20) and recharge-free (F15) implantable SNM systems that delivers mild electrical pulses to the targeted sacral nerve to restore normal communication to and from the brain to reduce the symptoms of bladder and bowel dysfunction. reduce the symptoms of OAB, UR, and FI. The company also offers Bulkamid, a urethral bulking agent to treat female stress urinary incontinence. It sells its products through a direct sales force and distributors in the United States, the United Kingdom, Germany, the Netherlands, Nordic countries, and internationally. The company was formerly known as Axonics Modulation Technologies, Inc. and changed its name to Axonics, Inc. in March 2021. Axonics, Inc. was incorporated in 2012 and is based in Irvine, California.
Investment Analysis Report: AXNX
Overview
In this investment analysis report, we will delve into the financial statements of AXNX, a company operating in the Health Technology sector within the Medical Specialties industry. We will analyze the company's financial health, earnings and revenue growth, profitability, operating margin, operating cas...
Technical Analysis of AXNX 2024-05-10
Overview:
In analyzing the technical indicators for AXNX over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key indicators, we aim to offer valuable insights and recommendations for potential...
Recent News & Updates
- 2024-05-16 16:01
- 2024-05-16 04:01
- 2024-04-30 16:08
Axonics: Q1 Earnings Snapshot(Associated Press Finance)
- 2024-04-30 16:01
Axonics Reports First Quarter 2024 Financial Results(Business Wire)
- 2024-04-30 09:56
- 2024-04-30 04:01
Axonics Reports First Quarter 2024 Financial Results(Businesswire)
- 2024-04-24 22:25
- 2024-04-24 06:30
- 2024-04-23 18:30
- 2024-03-29 12:00
- 2024-03-29 00:00
- 2024-03-22 16:01
- 2024-03-22 04:01
- 2024-03-21 16:54
Axonics Provides Update on Inter Partes Review Proceedings(Business Wire)
- 2024-03-21 04:54
- 2024-03-14 20:53
- 2024-03-14 06:00
- 2024-03-13 18:00
- 2024-03-01 14:22
Axonics Full Year 2023 Earnings: EPS Beats Expectations(Simply Wall St.)
- 2024-02-29 16:01
Axonics Responds to ITC Action by Medtronic(Business Wire)
- 2024-02-29 03:01
Axonics Responds to ITC Action by Medtronic(Businesswire)
- 2024-02-28 19:01
- 2024-02-28 17:40
- 2024-02-28 16:41
Axonics: Q4 Earnings Snapshot(Associated Press Finance)
- 2024-02-28 16:01
- 2024-02-28 03:01
- 2024-02-02 21:09
- 2024-01-31 06:30
- 2024-01-30 17:30
- 2024-01-29 10:02
Page 1 of 5
previousnext